Prof. Gerald Fogarty

  • BSc MBBS PhD FRANZCR (FRO)
  • Radiation Oncologist
  • Spoken languages English

Overview

Special clinical interest in Radiation treatment of skin disease.

Professor Gerald B. Fogarty FRANZCR, PhD is Director of Radiation Oncology at Mater Hospital, Sydney. He trained at Peter MacCallum Cancer Centre. He is also a radiation oncologist with Melanoma Institute of Australia. He authored the radiotherapy section of the 2019 NHMRC Management of Keratinocyte Guidelines. He is a board member of the Melanoma and Skin Cancer Trials Group and Chair of the Australian Merkel Interest Group.

His career goal is to establish level one evidence for radiation in skin disease. He is an active researcher having over 150 publications and he has a H index of 25.. For his skin publications see www.drgeraldfogarty.com/publications. This website is updated annually. He is currently the Master of Warrane College, an affiliated residential College at UNSW.

Awards received

  • Varian Prize (best registrar presentation at annual national scientific meeting of RANZCR) 2000
  • The most accessed journal article by dermatologists worldwide during March 2014 according to Medscape (Article: Fogarty, G. B., A. Hong, R. A. Scolyer, E. Lin, L. Haydu, P. Guitera, and J. Thompson. “Radiotherapy for lentigo maligna: a literature review and recommendations for treatment.” British Journal of Dermatology 170, no. 1 (2014): 52-58)

Research interests

Developing the level one evidence to define the place of radiotherapy in the skin disease. Other clinical interests include patient advocacy.

Publications and affiliations

  • Volumetric modulated arc therapy (VMAT) for skin field cancerisation of the nose – A technique and case report. Martin TD, Moutrie Z, Tighe D, et al. Int J Radiol Radiat Ther. 2018;5(3):142‒148. DOI: 10.15406/ijrrt.2018.05.00152 http://medcraveonline.com/IJRRT/IJRRT-05-00152.pdf
  • Common dermatology questions and answers about the radiation treatment of skin cancer in the modern era. Fogarty GB, Shumack S. Int J Radiol Radiat Ther. 2018;5(2):108‒114. DOI: 10.15406/ijrrt.2018.05.00145 http://medcraveonline.com/IJRRT/IJRRT-05-00145.pdf
  • Superficial X-ray radiotherapy results in tissue conservation and long-term control of melanoma in situ of the lower eyelid. Fogarty GB, Ziebell A, Nicholls S, Kulasekara S, Duthie D, Tumuluri K. Int J Radiol Radiat Ther. 2019;6(4):140‒142. DOI: 10.15406/ijrrt.2019.06.00235 https://medcraveonline.com/IJRRT/IJRRT-06-00235.pdf
  • Less is more when treating the nasal ala with superficial radiotherapy. Butcher LM, Fogarty GB, Sinclair S, et al. Int J Radiol Radiat Ther. 2020;7(3):66‒69. DOI: 10.15406/ijrrt.2020.07.00267 https://medcraveonline.com/IJRRT/IJRRT-07-00267.pdf
  • Split Course Superficial Radiotherapy in Scrotal Extramammary Paget’s Disease Allows Course Completion With Minimal Side Effects: A Case Study Gerald B Fogarty, Joanne Sullivan, Tina Gorjiara, Leslene Diedericks, Keng-Ee Thai. J. of Dermatological Res. 2020 April; 5(1): 202-205. ISSN 2413-8223 http://www.ghrnet.org/index.php/jdr/article/view/2886/3171

Professional memberships

  • MASC
  • AMIGOs
  • ASTRO
  • RANZCR
  • MIA